Methionine enkephalin suppresses metabolic activity of a leukemic cell line (NALM-1) and enhances CD10 expression

International Immunopharmacology

Volumn 3, Issue 5, 2003, Pages 707-711

  Martin Kleiner, Irena ^a   Gabrilovac, Jelka ^a   Kušec, Rajko ^b   Boranić, Milivoj ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b University of Zagreb   (Croatia)

Author keywords

CD10; Leukemic cell line; Neutral endopeptidase; Opioid peptides; RT PCR; Thiorphan

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; METENKEPHALIN; RNA; TETRAZOLIUM; THIORPHAN;

ANTIGEN EXPRESSION; ARTICLE; CELL METABOLISM; CELL TRANSPORT; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0038730809     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00058-4     Document Type: Article

References (25)

1. Plotnikoff N.P., Faith R.E., Murgo A.J., Herberman R.B., Good R.A. Methionine enkephalin: a new cytokine-human studies. Clin. Immunol. Immunopathol. 82:1997;93-101.
2. Zagon I.S., Smith J.P., McLaughlin P.J. Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor. Int. J. Oncol. 14:1999;577-584.
3. Zagon I.S., Roesener C.D., Verderame M.F., Ohlsson-Wilhelm B.M., Levin R.J., McLaughlin P.J. Opioid growth factor regulates the cell cycle of human neoplasias. Int. J. Oncol. 17:2000;1053-1061.
4. Mernenko O.A., Blishchenko E.Y., Mirkina I.I., Karelin A.A. Met-enkephalin induces cytolytic process of apoptotic type in K-562 human erythroid leukemia cells. FEBS Lett. 383:1996;230-232.
5. Balog T., Marotti T., Musani V., Sobočanec S., Šverko V. The effect of methionine-enkephalin on nitric oxide release in mice is age and gender related. Pharmacol. Res. 44:2001;287-292.
6. Krizanac-Bengez L.J., Breljak D., Boranic M. Suppressive effect of Met-enkephalin on bone marrow cell proliferation in vitro shows circardian pattern and depends on the presence of adherent accessory cells. Biomed. Pharmacother. 50:1996;85-91.
7. Breljak D., Boranić M., Horvat S. Oligopeptide fragments of the enkephalin molecule interfere with hematopoetic cell colony formation. Int. J. Immunopathol. Pharmacol. 13:2000;13-19.
8. Kowalski J. Immunologic action of [Met(5)]enkephalin fragments. Eur. J. Pharmacol. 347:1998;95-99.
9. Jongeneel C.V., Quackenbush E.J., Ronco P., Verroust P., Carrel S., Letarte M. Common acute lymphoblastic leukemia antigen expressed on leukemia and melanoma cell lines has neutral endopeptidase activity. J. Clin. Invest. 83:1989;713-717.
10. Letarte M., Vera S., Tran R., Addis J.B., Onizuka R.J., Quackenbush E.J.et al. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase. J. Exp. Med. 168:1988;1247-1253.
11. Shipp M.A., Tarr G.E., Chen C.Y., Switzer S.N., Hersh L.B., Stein H.et al. CD10/neutral endopeptidase 24.11. hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. Proc. Natl. Acad. Sci. U. S. A. 88:1991;10662-10666.
12. Mentlein R., Ross T. Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells. Peptides. 17:1996;709-720.
13. Shipp M.A., Richardson N.E., Sayre P.H., Brown N.R., Masteller E.L., Clayton L.K.et al. Molecular cloning of the common acute lymphoblastic keukemia antigen (CALLA) identifies a type II integral membrane protein. Proc. Natl. Acad. Sci. U. S. A. 85:1988;4819-4823.
14. Heagy W., Teng E., Lopez P., Finberg R.W. Enkephalin receptors and receptor-mediated signal transduction in cultured human lymphocytes. Cell. Immunol. 191:1999;34-48.
15. Kubonishi I., Freeman A.I., Minowada J. Heterotransplantation and clonal growth of human Ph′-chromosome positive leukemia-cell (NALM-1) and B-cell leukemia-cell (BALM-2) lines. Cancer. 45:1980;2324-2329.
16. Roques B.P., Fournie-Zaluski M.C., Soroca E., Lecomte J.M., Malfroy B., Llorens C.et al. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature. 288:1980;286-288.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
18. Burek B., Hršak I. In vitro modulation of preleukemic AKR mouse macrophage function by bacterial immunomodulators. Immunol. Lett. 45:1995;185-188.
19. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
20. Kusec R. Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR). Lo Y.M.D. Methods in molecular medicine, clinical application of PCR. vol. 16:1999;149-158 Humana Press, Totowa, NJ.
21. Watzinger F., Lion T. Multiplex PCR for quality control of template RNA/cDNA in RT-PCR assays. Leukemia. 12:1998;1984-1986.
22. Wang Y., Wang X.-M., Han J.-S. Discrimination between peptide and non-peptide opioid agonists on the transcription of opioid receptors in two cell lines. Life Sci. 68:2001;2731-2740.
23. Morgan E.L. Regulation of human B lymphocyte activation by opioid peptide hormones-inhibition of IgG production by opioid receptor class (mu-, kappa-, and delta-) selective agonists. J. Neuroimmunol. 65:1996;21-30.
24. House R.V., Thomas P.T., Bhargava N. A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides. Peptides. 17:1996;75-81.
25. Thierry M., Mitsuhara K., Lucette D., Pierre D., Claude G., Nadine N.et al. Importance of amine bond of thiorphan in the inhibitor enkephalinase docking process demonstrated with some thiorphan isoesters. Bioorg. Med. Chem. Lett. 2:1992;949-954.